These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 119800)
21. Normal serum triiodothyronine concentration and the lack of TSH response to TRH in patients with euthyroid Graves' disease. Shimizu T; Shishiba Y Endocrinol Jpn; 1973 Oct; 20(5):527-8. PubMed ID: 4209648 [No Abstract] [Full Text] [Related]
22. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease. De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104 [TBL] [Abstract][Full Text] [Related]
23. T3-release from autonomously functioning thyroid nodules in vitro. Poertl S; Kirner J; Saller B; Mann K; Hoermann R Exp Clin Endocrinol Diabetes; 1998; 106(6):489-93. PubMed ID: 10079030 [TBL] [Abstract][Full Text] [Related]
25. [Variation of the thyrotropin-releasing-hormone (TRH) stimulated thyrotropin (TSH) response in comparison with the tyhroid-gland-suppression test and the triiodothyronine (T3) and thyroxine (T4) blood levels in the so-called euthyroid endocrine ophthalmopathy]. Wenzel KW Endokrinologie; 1975 Sep; 66(1):67-73. PubMed ID: 1243821 [TBL] [Abstract][Full Text] [Related]
26. Radioimmunoassay of thyrotropin-releasing hormone in euthyroid subjects and in patients with thyroid diseases. Földes J; Mohari K; Janoki G; Tarjan G; Varga F Acta Med Austriaca; 1992; 19 Suppl 1():83-5. PubMed ID: 1519462 [TBL] [Abstract][Full Text] [Related]
27. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy. Lytton SD; Ponto KA; Kanitz M; Matheis N; Kohn LD; Kahaly GJ J Clin Endocrinol Metab; 2010 May; 95(5):2123-31. PubMed ID: 20237164 [TBL] [Abstract][Full Text] [Related]
28. [Radioimmunological and immunological follow-up of toxic goiter remission following radiotherapy and thyroidectomy]. Ametov AS; Livshits AKh; Oleĭnik EK Med Radiol (Mosk); 1987 Feb; 32(2):38-41. PubMed ID: 3100903 [TBL] [Abstract][Full Text] [Related]
29. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients. Banovac K; Zakarija M; McKenzie JM; Witte A; Sekso M J Clin Endocrinol Metab; 1981 Sep; 53(3):651-3. PubMed ID: 6790561 [TBL] [Abstract][Full Text] [Related]
31. Serum TSH measurements by a sensitive enzyme immunoassay discriminate euthyroid from hyperthyroid subjects and avoid the need for TRH test during suppressive therapy with L-thyroxine. Grasso L; Bartalena L; Mammoli C; Martino E; Kessler AC; Pinchera A Clin Biochem; 1987 Jun; 20(3):197-200. PubMed ID: 3115625 [TBL] [Abstract][Full Text] [Related]
32. Plasma free triiodothyronine response to thyrotropin-releasing hormone to predict the remission of Graves' disease treated with antithyroid drugs. Notsu K; Oka N; Masaki Y; Furuya H; Kato Y J Clin Endocrinol Metab; 1991 Aug; 73(2):396-400. PubMed ID: 1713218 [TBL] [Abstract][Full Text] [Related]
33. Thyrotropin secretion in thyrotoxic and thyroxine-treated patients: assessment by a sensitive immunoenzymometric assay. Spencer CA; Lai-Rosenfeld AO; Guttler RB; LoPresti J; Marcus AO; Nimalasuriya A; Eigen A; Doss RC; Green BJ; Nicoloff JT J Clin Endocrinol Metab; 1986 Aug; 63(2):349-55. PubMed ID: 3088021 [TBL] [Abstract][Full Text] [Related]
34. Is TPO detectable in the circulation? Premawardhana LD; Kiso Y; Phillips DI; Morteo C; Furmaniak J; Rees Smith B Thyroid; 1993; 3(3):225-8. PubMed ID: 8257863 [TBL] [Abstract][Full Text] [Related]
35. Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays. Spencer CA; Schwarzbein D; Guttler RB; LoPresti JS; Nicoloff JT J Clin Endocrinol Metab; 1993 Feb; 76(2):494-8. PubMed ID: 8432796 [TBL] [Abstract][Full Text] [Related]
36. Sub-biochemical hypothyroidism: an exaggerated thyroid stimulating hormone response to thyrotrophin releasing hormone. Sheth JJ; Thakore PB; Trivedi BB; Shah NN; Vaidya RA J Assoc Physicians India; 1999 Mar; 47(3):275-9. PubMed ID: 10999119 [TBL] [Abstract][Full Text] [Related]
37. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs. Buerklin EM; Schimmel M; Utiger RD J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733 [TBL] [Abstract][Full Text] [Related]
38. [TRH test after subtotal thyroid resection for diffuse toxic goiter]. Ibragin Md; Bazarova EN; Kandror VI Probl Endokrinol (Mosk); 1985; 31(6):12-6. PubMed ID: 3937156 [TBL] [Abstract][Full Text] [Related]
39. Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3. Burman KD; Dimond RC; Earll JM; Wright FD; Wartofsky L J Clin Endocrinol Metab; 1976 Sep; 43(3):606-13. PubMed ID: 989049 [TBL] [Abstract][Full Text] [Related]
40. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents. Wood LC; Ingbar SH J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]